Can a ginkgo supplement beat stress and boost memory?
NCT ID NCT06583941
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether a dietary supplement called Virtiva Plus, which contains ginkgo biloba, can help reduce stress and improve thinking in people aged 50 to 70 who feel stressed. Sixty participants took either a low or high dose twice daily for five weeks. Researchers measured anxiety, mood, memory, and quality of life using questionnaires and computer tests.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Virtiva Plus (dietary supplement with ginkgo biloba extract)
- What this could lead to
- If it works, this could point toward a natural supplement option for easing stress and supporting memory in midlife.
- What could go wrong
- This is a small, completed study with only 60 participants. Results may not apply to everyone, and supplements can have side effects or interact with medications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Apr 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 70 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female * Aged 50 to 70 years (both limits inclusive) * Body mass index (BMI) value of 18.5-29.99 kg/m2 * Willing and able to give written informed consent * Able to read, understand, sign and date the informed consent document (English only) * Able and willing to comply with the schedule visit(s) and study requirements. * Willing to consume the investigational study product 2 times per day for 5 weeks. * Willing to maintain a habitual diet and avoid changes during the study period (for example, intermittent fasting, ketogenic diet, Atkins diet, meatless diet, etc.). * Willing to cease from consuming cognitive enhancement supplements 7 days prior to and after the study commencement, until the end of the study. Exclusion Criteria: * Developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to follow study subject requirements and/or record the necessary study measurements. * History of cardiovascular disease (i.e., myocardial infarction, hypertension, hypercholesterolemia, peripheral vascular disease, other) * History of neurological disorders (Parkinson's, Amyotrophic lateral sclerosis, epilepsy, spinal cord injury resulting in inability to use upper extremities, other) * History of gastrointestinal disorders that could lead to uncertain absorption of the study supplements, (i.e., inflammatory bowel disease, ulcerative colitis, Crohn's disease, colostomy, or eating disorder) * History of kidney or liver disease * History of metabolic disorders (diabetes, metabolic syndrome, other) * History or current malignancy * Receiving chemotherapy agents or radiation treatments * Diagnosis of a terminal illness * Pregnancy or has breast fed within 3 months prior to enrollment * Use of prescription medications that impact digestion (i.e., proton pump inhibitor medications, other) * History or current alcohol or drug abuse * Has significant concurrent illnesses (controlled or uncontrolled), such as lupus, hepatitis B/C, HIV, serious mental health illness such as dementia or schizophrenia; psychiatric hospitalization in the past two years, or other, which in the opinion of the investigator, such condition might be aggravated as a result of treatment * The investigator feels that for any reason the subject is not eligible to participate in the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive change are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Applied Science and Performance Institute
Tampa, Florida, 33634, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can free groceries and classes rewire daily health habits?
- Can a rewired EMDR therapy ease the mental toll of migration?
- Can beef power firefighter recovery?
- Can a single audio hypnosis session calm exam nerves and boost test scores?
- Can pork protein speed recovery after firefighting?
- Medical Students' stress hormones measured during real patient encounters